Aclaris Therapeutics, Inc. (ACRS) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 2M | 1.29M | 3.3M | 1.78M | 1.46M | 9.21M | 4.35M | 2.77M | 2.4M | 17.57M | 9.28M | 1.87M | 2.53M | 7.75M | 19.02M | 1.53M | 1.45M | 1.5M | 1.66M | 1.82M |
| Revenue Growth % | 37.18% | -85.94% | -24.09% | -35.76% | -39.32% | -47.58% | -53.18% | 47.99% | -5.14% | 126.62% | -51.19% | 22.32% | 73.98% | 416.52% | 1046.35% | -16.23% | -18.23% | -5% | 14.49% | -10.85% |
| Cost of Goods Sold | 395K | -803K | 538K | 1.85M | 506K | 9.3M | 2.41M | 1.91M | 1.84M | 6.43M | 8.19M | 1.59M | 1.87M | 1.51M | 8.22M | 1.07M | 1.16M | 1.15M | 1.1M | 1.26M |
| COGS % of Revenue | 19.79% | -62.01% | 16.31% | 104.11% | 34.78% | 100.98% | 55.41% | 69.02% | 76.73% | 36.59% | 88.26% | 85.18% | 73.93% | 19.53% | 43.24% | 69.9% | 79.49% | 76.55% | 66.24% | 69.24% |
| Gross Profit | 1.6M | 2.1M | 2.76M | -73K | 949K | -90K | 1.94M | 857K | 558K | 11.14M | 1.09M | 277K | 659K | 6.24M | 10.79M | 460K | 298K | 352K | 560K | 561K |
| Gross Margin % | 80.21% | 162.01% | 83.69% | -4.11% | 65.22% | -0.98% | 44.59% | 30.98% | 23.27% | 63.41% | 11.74% | 14.82% | 26.07% | 80.47% | 56.76% | 30.1% | 20.51% | 23.45% | 33.76% | 30.76% |
| Gross Profit Growth % | 68.7% | 2431.11% | 42.47% | -108.52% | 70.07% | -100.81% | 77.8% | 209.39% | -15.33% | 78.59% | -89.9% | -39.78% | 121.14% | 1672.44% | 1827.68% | -18% | -48.17% | 19.73% | 115.38% | -14.61% |
| Operating Expenses | 23.79M | 24.83M | 19.91M | 18.34M | 19.03M | 99.58M | 12.41M | 13.71M | 19.49M | 15.19M | 32.67M | 32.09M | 30.58M | 35.32M | 31.67M | 21.45M | 19.2M | 23.25M | 20.86M | 18.57M |
| OpEx % of Revenue | 1192.03% | 1917.53% | 603.52% | 1031.8% | 1308.11% | 1081.15% | 285.53% | 495.7% | 812.72% | 86.45% | 351.94% | 1717.07% | 1209.53% | 455.54% | 166.52% | 1404.06% | 1321.75% | 1548.63% | 1257.08% | 1017.93% |
| Selling, General & Admin | 6.74M | 5.58M | 4.87M | 5.39M | 6.14M | 4.95M | 5.65M | 4.65M | 6.84M | 8.21M | 6.8M | 7.3M | 8.79M | 7.15M | 5.81M | 6.08M | 6.1M | 6.94M | 5.98M | 5.87M |
| SG&A % of Revenue | 337.83% | 430.58% | 147.65% | 303.1% | 421.92% | 53.78% | 130.07% | 168.19% | 285.4% | 46.75% | 73.24% | 390.37% | 347.71% | 92.17% | 30.57% | 397.58% | 419.75% | 462.56% | 360.4% | 321.82% |
| Research & Development | 15.66M | 16.58M | 13.03M | 11.45M | 11.58M | 9.03M | 5.96M | 8.76M | 9.85M | 26.65M | 23.88M | 25.27M | 22.59M | 21.07M | 23.66M | 18.78M | 14.31M | 14.1M | 13.98M | 7.9M |
| R&D % of Revenue | 784.42% | 1280.62% | 394.91% | 644.29% | 796.15% | 97.99% | 137.05% | 316.67% | 410.55% | 151.66% | 257.23% | 1352.33% | 893.47% | 271.79% | 124.39% | 1228.99% | 984.58% | 939.51% | 842.44% | 432.95% |
| Other Operating Expenses | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 800K | 300K | 1000K | -1000K | 1000K | -479K | -800K | 1000K | 1000K | -1000K | -1000K | 1000K | 900K | 1000K |
| Operating Income | -22.19M | -22.73M | -17.15M | -18.41M | -18.08M | -99.67M | -10.47M | -12.85M | -18.93M | -4.05M | -31.58M | -31.82M | -29.92M | -29.08M | -20.87M | -20.99M | -18.91M | -22.89M | -20.3M | -18.01M |
| Operating Margin % | -1111.82% | -1755.52% | -519.82% | -1035.9% | -1242.89% | -1082.13% | -240.93% | -464.71% | -789.45% | -23.03% | -340.2% | -1702.25% | -1183.47% | -375.07% | -109.76% | -1373.95% | -1301.24% | -1525.18% | -1223.33% | -987.17% |
| Operating Income Growth % | -22.72% | 77.19% | -63.78% | -43.21% | 4.47% | -2362.94% | 66.84% | 59.6% | 36.72% | 86.08% | -51.27% | -51.54% | -58.24% | -27.02% | -2.85% | -16.59% | 33.73% | -68.83% | -93.93% | -58.21% |
| EBITDA | -22.09M | -22.63M | -16.94M | -18.29M | -17.96M | -99.53M | -10.29M | -12.81M | -18.69M | -3.82M | -31.36M | -31.6M | -29.72M | -28.89M | -20.68M | -20.79M | -18.7M | -22.7M | -20.1M | -17.76M |
| EBITDA Margin % | -1106.71% | -1747.64% | -513.46% | -1029.49% | -1234.09% | -1080.58% | -236.82% | -463.2% | -779.32% | -21.74% | -337.84% | -1690.58% | -1175.63% | -372.62% | -108.74% | -1360.47% | -1286.92% | -1512.06% | -1211.81% | -973.63% |
| EBITDA Growth % | -23.02% | 77.26% | -64.58% | -42.79% | 3.92% | -2506.23% | 67.18% | 59.45% | 37.12% | 86.78% | -51.63% | -52% | -58.94% | -27.29% | -2.87% | -17.06% | 33.79% | -62.01% | -103.61% | -64.82% |
| D&A (Non-Cash Add-back) | 102K | 102K | 210K | 114K | 128K | 143K | 179K | 42K | 243K | 228K | 219K | 218K | 198K | 190K | 193K | 206K | 208K | 197K | 191K | 247K |
| EBIT | -22.19M | -19.8M | -14.61M | -16.91M | -17.78M | -14.07M | -9.67M | -12.65M | -16.13M | -23.72M | -29.58M | -32.29M | -30.72M | -21.98M | -18.67M | -24.39M | -20.11M | -20.69M | -19.39M | -13.21M |
| Net Interest Income | 1.51M | 1.63M | 1.82M | 2.02M | 2.17M | 2.1M | 1.99M | 1.87M | 1.99M | 0 | 2.32M | 0 | 0 | 0 | -1.28M | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 1.51M | 1.63M | 1.82M | 2.02M | 2.17M | 2.1M | 1.99M | 1.87M | 1.99M | 0 | 2.32M | 0 | 0 | 0 | 922K | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.2M | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.37M | 2.94M | 2.54M | 2.98M | 3M | 3.12M | 2.88M | 1.87M | 1.99M | 2.19M | 2.32M | 2.25M | 1.76M | 1.44M | 922K | 462K | 118K | 89K | -851K | -155K |
| Pretax Income | -19.82M | -19.8M | -14.61M | -15.43M | -15.09M | -96.55M | -7.59M | -10.99M | -16.94M | -1.86M | -29.26M | -29.57M | -28.16M | -27.64M | -19.95M | -20.53M | -18.79M | -22.8M | -21.15M | -18.16M |
| Pretax Margin % | -993.19% | -1528.57% | -442.98% | -868.26% | -1036.77% | -1048.22% | -174.55% | -397.18% | -706.46% | -10.57% | -315.24% | -1582.08% | -1113.92% | -356.44% | -104.91% | -1343.72% | -1293.12% | -1519.25% | -1274.62% | -995.67% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -367K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 19.75% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -19.82M | -19.8M | -14.61M | -15.43M | -15.09M | -96.55M | -7.59M | -10.99M | -16.94M | -1.49M | -29.26M | -29.57M | -28.16M | -27.64M | -19.95M | -20.53M | -18.79M | -22.8M | -21.15M | -18.16M |
| Net Margin % | -993.19% | -1528.57% | -442.98% | -868.26% | -1036.77% | -1048.22% | -174.55% | -397.18% | -706.46% | -8.49% | -315.24% | -1582.08% | -1113.92% | -356.44% | -104.91% | -1343.72% | -1293.12% | -1519.25% | -1274.62% | -995.67% |
| Net Income Growth % | -31.42% | 79.5% | -92.64% | -40.44% | 10.96% | -6375.65% | 74.07% | 62.85% | 39.84% | 94.6% | -46.66% | -44.01% | -49.87% | -21.18% | 5.65% | -13.06% | 34.66% | -73.11% | -98.39% | -56.6% |
| Net Income (Continuing) | -19.82M | -19.8M | -14.61M | -15.43M | -15.09M | -96.55M | -7.59M | -10.99M | -16.94M | -1.49M | -29.26M | -29.57M | -28.16M | -27.64M | -19.95M | -20.53M | -18.79M | -22.8M | -21.15M | -18.16M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.15 | -0.16 | -0.12 | -0.13 | -0.12 | -1.01 | -0.11 | -0.15 | -0.24 | -0.02 | -0.41 | -0.42 | -0.39 | -0.50 | -0.32 | -0.25 | -0.28 | -0.37 | -0.35 | -0.34 |
| EPS Growth % | -25% | 84.16% | -9.09% | 13.33% | 50% | -4709.52% | 73.17% | 64.29% | 38.46% | 95.8% | -28.13% | -68% | -39.29% | -35.14% | 8.57% | 26.47% | 50.88% | -23.33% | -40% | -21.43% |
| EPS (Basic) | -0.15 | -0.16 | -0.12 | -0.13 | -0.12 | -1.01 | -0.11 | -0.15 | -0.24 | -0.02 | -0.41 | -0.42 | -0.39 | -0.50 | -0.32 | -0.25 | -0.28 | -0.37 | -0.35 | -0.34 |
| Diluted Shares Outstanding | 128.81M | 122.66M | 122.62M | 122.58M | 122.39M | 95.31M | 71.38M | 71.29M | 71.07M | 70.87M | 70.81M | 70.63M | 66.87M | 66.69M | 66.68M | 65.99M | 61.43M | 61.23M | 61.22M | 53.97M |
| Basic Shares Outstanding | 128.81M | 122.66M | 122.62M | 122.58M | 122.39M | 95.31M | 71.38M | 71.29M | 71.07M | 70.87M | 70.81M | 70.63M | 66.87M | 66.69M | 66.68M | 65.99M | 61.43M | 61.23M | 61.22M | 53.97M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |